TKMR News 18.56 09/08/2014 05:37:29 Tekmira Pharmaceuticals Corp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tekmira Pharmaceuticals Corp (TKMR) 18.56 $TKMR

'Mad Money' Lightning Round: I Still Want to Own Freeport-McMoRan
at The Street - Sat Sep 06, 5:00AM CDT
Cramer likes Take-Two Interactive over Activision Blizzard and if you wanted Tekmira Pharmaceuticals you're too late.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Sep 05, 6:37PM CDT
Cramer is looking for bargains, and that means he'll be watching Yahoo!, Apple and Restoration Hardware next week.

J&J Ebola Vaccine Gets Funding, Development to Pick Pace - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 2:37PM CDT
Johnson & Johnson (JNJ) announced that its Ebola vaccine development process will be fast-tracked.

Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
PR Newswire - Thu Sep 04, 7:55AM CDT
On Wednesday, September 03, 2014, the NASDAQ Composite ended at 4,572.57, down 0.56%, the Dow Jones Industrial Average finished the day 0.06% higher at 17,078.28, and the S&P 500 closed at 2,000.72, down 0.08%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 740.75, up 0.41%, with the index advancing 6.93% in the previous three months. Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Arrowhead Research Corporation (NASDAQ: ARWR), Celgene Corporation (NASDAQ: CELG), and Amgen Inc. (NASDAQ: AMGN). Free research on these five companies can be accessed at:

BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:08PM CDT
BioCryst 's (BCRX) BCX4430 will be evaluated in a non-human primate study shortly.

Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:50PM CDT
Glaxo's Ebola vaccine development process has been fast-tracked by an international consortium.

Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK
PR Newswire - Tue Sep 02, 8:00AM CDT
Today, Analysts Review released its research reports regarding WellPoint Inc. (NYSE: WLP), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Zoetis Inc. (NYSE: ZTS), Sanofi SA (NYSE: SNY) and GlaxoSmithKline plc (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6142-100free.

Nasdaq stocks posting largest percentage increases
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

'Fast Money' Recap: When Is the Next Market Correction?
at The Street - Fri Aug 29, 4:00AM CDT
The trading panel discussed when the market will pull back, cyber attacks and the company making Apple's sapphire screens.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Surging Today
at The Street - Thu Aug 28, 10:12AM CDT
Tekmira Pharmaceuticals (TKMR) surged Thursday as takeover talks swirl around the Vancouver-based biotech company.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today
at The Street - Thu Aug 21, 9:30AM CDT
Monkeys sickened by Marburg virus, an Ebola relative that kills in the same way and is equally as fatal, survived the disease after being treated with its experimental drug.

Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock
at The Street - Thu Aug 21, 8:45AM CDT
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate

The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, GileadSciences, Allergan and Supernus Pharmaceuticals
PR Newswire - Thu Aug 21, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Johnson & Johnson (NYSE:JNJ-Free Report), Tekmira Pharmaceuticals Corp (Nasdaq:TKMR-Free Report), Gilead Sciences Inc. (Nasdaq:GILD-Free Report), Allergan Inc. (NYSE:AGN-Free Report) and Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN-Free Report).

Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 3:27PM CDT
Favorable industry trends in the pharma and bio-tech space makes the healthcare sector a lucrative investment destination.

Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication
GlobeNewswire - Wed Aug 20, 1:00PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive results in an animal model of Marburg virus infection enabled by Tekmira's lipid nanoparticle (LNP) technology.

5 Stocks Jumping on Unusual Volume
at The Street - Tue Aug 19, 5:30AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today
at The Street - Mon Aug 18, 12:29PM CDT
Tekmira Pharmaceuticals (TKMR) shares are up double digits after having coverage initiated with an 'outperform' rating and $25 price target by analysts at Leerink.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 118

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
DAR Logs Massive 587,000 Service Hours Nationwide

Updated Category News Views 74

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Continue Reading
ID Plans Secures Polaris Investment for Real Estate Boost

Updated Category News Views 0

New Moves in Real Estate Tech Can you smell opportunity? Because it’s in the air down in Tampa where ID Plans just inked a deal with Polaris Growth Fund. We’re talking some serious private equity backing here aimed at ramping up what ID Plans can lay down in the commercial real estate sector. If you're not on this ride yet, it might be time to take a closer look....

Continue Reading
SeaWorld Rings in Holidays with All-New Festivities

Updated Category News Views 9

Holiday Transformation at SeaWorld's Parks The holiday spirit isn't something you purchase—it’s an experience. And boy, SeaWorld seems to get this right. As the chill of late October settles in, SeaWorld parks across Orlando, San Diego, and San Antonio start dressing up for the holiday season, morphing into a spectacle of lights and festive joy. For anyone who’s...

Continue Reading
Energizer Set to Unveil Q4 and Full Year 2026 Results

Updated Category News Views 32

Call in and Batten Down the Hatches November 17—Mark it. Energizer Holdings, Inc. (NYSE: ENR) is taking the stage to deliver its Fourth Quarter and full fiscal year 2026 financial showing. If you're tailing the power-boosting giant's dance in the market, then clear your morning schedule for a 10 a.m. ET webinar. CEO Mark LaVigne and CFO John Drabik are dialing up their...

Continue Reading
Famous Brands Slashes Fees to Boost Franchise Growth

Updated Category News Views 17

Throwing a Sweet Deal for New Franchise Owners Talk about a move that’s got the industry buzzing—Famous Brands International, the folks behind Mrs. Fields and TCBY, just rolled out a tantalizing offer you don’t see every day. They’re slashing franchise fees and royalties by half for new franchisees who jump onboard before the ball drops on 2026. I’ll tell ya,...

Continue Reading
Armani/Casa Miami Earns Forbes Designation for Luxury

Updated Category News Views 54

Where Luxury Meets Thoughtfulness Residences by Armani/Casa Miami just nabbed a VERIFIED™ Luxury Residences badge from the Forbes Travel Guide folks. Now, you might be wondering why this is significant or if it's just another shiny tag in a world already glistening with luxury concepts. Well, there's a shift happening here, and it's got some meat to it. The folks...

Continue Reading
kidSTREAM Museum Welcomes Carina Reeves as New CEO

Updated Category News Views 93

Carina Reeves Takes the Helm at kidSTREAM You know how it goes—sometimes you need fresh leadership to steer the ship. That's exactly what's happening over at kidSTREAM Children's Museum. They've appointed Carina Reeves as their President and CEO after a nationwide hunt. This ain't just another CEO shuffle; it marks a pivotal moment as kidSTREAM inches closer to its...

Continue Reading
Max Stock Gears Up for Q3 Earnings Report Nov. 17

Updated Category News Views 0

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 36

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Retail with Vantage and Quid's Unique Partnership

Updated Category News Views 245

Introduction to a New Era in Retail Intelligence In a rapidly evolving retail landscape, the partnership between Vantage Discovery and Quid marks a significant leap towards integrating advanced technology with consumer insights. Vantage Discovery, recognized for its cutting-edge AI-powered search and personalization solutions, is teaming up with Quid, a leader in trend...

Continue Reading
Ellington Financial Inc. Achieves Milestone in Non-QM Market

Updated Category News Views 195

Ellington Financial Inc. Celebrates Non-QM Securitization Success Ellington Financial Inc. (NYSE: EFC) has reached a significant milestone with the successful closing of a $288 million securitization, which is backed by a pool of non-qualified residential mortgage (non-QM) loans. This achievement underscores the Company’s commitment to innovating in the mortgage market....

Continue Reading
Ryman Hospitality Properties, Inc. Enhances Investor Insights

Updated Category News Views 124

Insights into Ryman Hospitality Properties, Inc. Ryman Hospitality Properties, Inc. (NYSE: RHP) is at the forefront of the hospitality and lodging industry, focusing on upscale group-oriented resorts and convention centers. This commitment to excellence enables the Company to provide memorable experiences, especially in country music entertainment. Updated Investor...

Continue Reading
Investing Insights: Understanding Your Rights as a Shareholder

Updated Category News Views 147

Understanding Your Rights as a Shareholder Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is currently investigating significant transactions involving certain public companies and their shareholders' rights. The firm primarily focuses on potential violations of federal...

Continue Reading
Bambusa Therapeutics Secures Series A-2 Financing to Boost Development

Updated Category News Views 337

Bambusa Therapeutics Completes Series A-2 Financing Successfully Bambusa Therapeutics, Inc., a prominent clinical-stage biotechnology firm specializing in next-generation bispecific antibodies for immunology and inflammation, has announced an important milestone: the completion of their oversubscribed Series A-2 financing. This achievement comes with a notable valuation...

Continue Reading